Variant report
Variant | nsv946479 |
---|---|
Chromosome Location | chr1:165549846-165553079 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:244)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr1:165550106-165550709 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr1:165550127-165550754 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr1:165550197-165550565 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr1:165550156-165550572 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | MYC | chr1:165550256-165550558 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | MYC | chr1:165551377-165551526 | MCF-7 | breast: | n/a | n/a |
7 | MYC | chr1:165550112-165550646 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr1:165551363-165551426 | A549 | lung: | n/a | n/a |
9 | POLR2A | chr1:165551240-165551517 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr1:165551480-165551497 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr1:165551459-165551490 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr1:165551228-165551474 | MCF-7 | breast: | n/a | n/a |
13 | STAT3 | chr1:165550203-165550443 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr1:165550247-165550746 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | STAT3 | chr1:165550247-165550707 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:165551490-165551540 | A549 | lung: | n/a |
2 | chr1:165550932-165550982 | BJ | skin: | n/a |
3 | chr1:165551210-165551260 | NB4 | blood: | n/a |
4 | chr1:165550932-165550982 | HIPEpiC | eye: | n/a |
5 | chr1:165551210-165551260 | AG09319 | gingival: | n/a |
6 | chr1:165551490-165551540 | PrEC | prostate: | n/a |
7 | chr1:165551490-165551540 | MCF10A-Er-Src | breast: | n/a |
8 | chr1:165551424-165551474 | Hepatocyte | liver: | n/a |
9 | chr1:165551490-165551540 | K562 | blood: | n/a |
10 | chr1:165551210-165551260 | MCF10A-Er-Src | breast: | n/a |
11 | chr1:165551424-165551474 | HRPEpiC | eye: | n/a |
12 | chr1:165550932-165550982 | T-47D | breast: | n/a |
13 | chr1:165550932-165550982 | U87 | brain: | n/a |
14 | chr1:165551210-165551260 | LNCaP | prostate: | n/a |
15 | chr1:165550932-165550982 | HRCEpiC | kidney: | n/a |
16 | chr1:165551490-165551540 | NH-A | brain: | n/a |
17 | chr1:165551210-165551260 | ovcar-3 | ovarian: | n/a |
18 | chr1:165551490-165551540 | GM12878 | blood: | n/a |
19 | chr1:165551490-165551540 | SKMC | muscle: | n/a |
20 | chr1:165551490-165551540 | HCM | heart: | n/a |
21 | chr1:165550932-165550982 | AG04450 | lung: | fetal |
22 | chr1:165551210-165551260 | Hela-S3 | cervix: | n/a |
23 | chr1:165551210-165551260 | BE2_C | brain: | n/a |
24 | chr1:165551210-165551260 | Caco-2 | colon: | n/a |
25 | chr1:165550932-165550982 | HAEpiC | amniotic membrane: | n/a |
26 | chr1:165550932-165550982 | PFSK-1 | brain: | n/a |
27 | chr1:165551490-165551540 | HRE | kidney: | n/a |
28 | chr1:165550932-165550982 | ProgFib | skin: | n/a |
29 | chr1:165551490-165551540 | RPTEC | kidney: | n/a |
30 | chr1:165551424-165551474 | K562 | blood: | n/a |
31 | chr1:165551210-165551260 | SK-N-SH_RA | brain: | n/a |
32 | chr1:165551424-165551474 | T-47D | breast: | n/a |
33 | chr1:165551210-165551260 | NH-A | brain: | n/a |
34 | chr1:165551210-165551260 | CMK | blood: | n/a |
35 | chr1:165550932-165550982 | ovcar-3 | ovarian: | n/a |
36 | chr1:165550932-165550982 | NT2-D1 | testis: | n/a |
37 | chr1:165551424-165551474 | RPTEC | kidney: | n/a |
38 | chr1:165550932-165550982 | PrEC | prostate: | n/a |
39 | chr1:165551490-165551540 | HUVEC | blood vessel: | n/a |
40 | chr1:165551424-165551474 | Hela-S3 | cervix: | n/a |
41 | chr1:165551490-165551540 | BJ | skin: | n/a |
42 | chr1:165550932-165550982 | HCM | heart: | n/a |
43 | chr1:165551210-165551260 | K562 | blood: | n/a |
44 | chr1:165550932-165550982 | HEK293 | kidney: | embryo |
45 | chr1:165550932-165550982 | ECC-1 | luminal epithelium: | n/a |
46 | chr1:165550932-165550982 | LNCaP | prostate: | n/a |
47 | chr1:165551210-165551260 | HRCEpiC | kidney: | n/a |
48 | chr1:165551490-165551540 | SK-N-SH_RA | brain: | n/a |
49 | chr1:165551210-165551260 | Hepatocyte | liver: | n/a |
50 | chr1:165551490-165551540 | GM06990 | blood: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:165548827..165550594-chr1:165555598..165558121,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RXRG-1 | chr1:165550764-165550815 | NONHSAT007311 |
2 | lnc-RXRG-1 | chr1:165550592-165550738 | NONHSAT007319 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237463 | TF binding region |
ENSG00000237783 | TF binding region |
ENSG00000237463 | CpG island |
ENSG00000237783 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549599237 | chr1:165549895-165549896 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs367732955 | chr1:165549917-165549918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141801583 | chr1:165549945-165549946 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551669666 | chr1:165550006-165550007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1572542 | chr1:165550009-165550010 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs537075059 | chr1:165550013-165550014 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559473739 | chr1:165550024-165550025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374827139 | chr1:165550090-165550091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142966821 | chr1:165550102-165550103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs151123836 | chr1:165550109-165550110 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs536057115 | chr1:165550112-165550113 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs368027220 | chr1:165550140-165550141 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs553085919 | chr1:165550182-165550183 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs73027009 | chr1:165550237-165550238 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs80003204 | chr1:165550251-165550252 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs113141238 | chr1:165550252-165550253 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs111840181 | chr1:165550253-165550254 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs77889171 | chr1:165550302-165550303 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs532660946 | chr1:165550325-165550326 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs73027011 | chr1:165550376-165550377 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs376116427 | chr1:165550390-165550391 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs575291590 | chr1:165550397-165550398 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs544261880 | chr1:165550422-165550423 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs74118820 | chr1:165550431-165550432 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs201412386 | chr1:165550461-165550462 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs61800650 | chr1:165550462-165550463 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs150744284 | chr1:165550467-165550468 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs186339925 | chr1:165550469-165550470 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs75900907 | chr1:165550471-165550472 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs141109226 | chr1:165550496-165550497 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs190840242 | chr1:165550549-165550550 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs41267552 | chr1:165550634-165550635 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs150183842 | chr1:165550640-165550641 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs530803382 | chr1:165550649-165550650 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs41267554 | chr1:165550654-165550655 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs138725571 | chr1:165550667-165550668 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs533434882 | chr1:165550679-165550680 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs536710035 | chr1:165550689-165550690 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs553207556 | chr1:165550695-165550696 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs566646693 | chr1:165550701-165550702 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs538867734 | chr1:165550773-165550774 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs554895597 | chr1:165550804-165550805 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs182105567 | chr1:165550823-165550824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544179789 | chr1:165550833-165550834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186571483 | chr1:165550836-165550837 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs41267556 | chr1:165550841-165550842 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs576989510 | chr1:165550846-165550847 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116383715 | chr1:165550884-165550885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559843292 | chr1:165550891-165550892 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs41267558 | chr1:165550894-165550895 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 22522925 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:165547400-165566800 | Weak transcription | Psoas Muscle | Psoas |
2 | chr1:165549000-165551000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr1:165549600-165551200 | Enhancers | NHEK | skin |
4 | chr1:165549600-165551600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr1:165549600-165551600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr1:165549800-165551600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr1:165550000-165550200 | Enhancers | Placenta | Placenta |
8 | chr1:165550200-165551400 | Enhancers | HMEC | breast |
9 | chr1:165550400-165551000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |